Elevance Health, Inc. (NYSE:ELV) is included among the 12 Best Long Term US Stocks to Buy Now. BofA Adjusts Elevance Health (ELV) Target to Reflect Higher Sector Valuations On December 16, BofA lifted its price target on Elevance Health, Inc. (NYSE:ELV) to $385 from$370 and kept a Neutral rating. The firm noted that its higher target reflects richer multiples across the peer group. Elevance Health, Inc. (NYSE:ELV)’s third-quarter results showed steady execution. The benefit expense ratio landed where m ...